During an infection, malaria parasites compete for limited amounts of food and enemy-free space. Competition affects parasite growth rate, transmission and virulence, and is thus important for parasite evolution. Much evolutionary theory assumes that virulent clones outgrow avirulent ones, favouring the evolution of higher virulence. We infected laboratory mice with a mixture of two Plasmodium chabaudi clones: one virulent, the other avirulent. Using real-time quantitative PCR to track the two parasite clones over the course of the infection, we found that the virulent clone overgrew the avirulent clone. However, host genotype had a major effect on the outcome of competition. In a relatively resistant mouse genotype (C57Bl/6J), the avirulent clone was suppressed below detectable levels after 10 days, and apparently lost from the infection. By contrast, in more susceptible mice (CBA/Ca), the avirulent clone was initially suppressed, but it persisted, and during the chronic phase of infection it did better than it did in single infections. Thus, the qualitative outcome of competition depended on host genotype. We suggest that these differences may be explained by different immune responses in the two mouse strains. Host genotype and resistance could therefore play a key role in the outcome of within-host competition between parasite clones and in the evolution of parasite virulence.
INTRODUCTION
According to a large body of theory, competition within hosts generates selection for pathogens that do more damage to their host (i.e. are more virulent; Levin & Pimentel 1981; Bremermann & Pickering 1983; Frank 1992 Frank , 1996 Van Baalen & Sabelis 1995; Gandon 1998; Mosquera & Adler 1998; Ebert 1999; Read et al. 2002) . Parasite fitness in singly infected hosts is assumed to be maximized when the benefits of host exploitation (increased transmission rate) balance the costs (increased host mortality) (Levin & Pimentel 1981; Anderson & May 1982; Bremermann & Pickering 1983; May & Anderson 1983; Sasaki & Iwasa 1991; Frank 1992 Frank , 1996 Antia et al. 1994; Van Baalen & Sabelis 1995; Antia & Lipsitch 1997) . But, in genetically diverse infections, parasites that slowly exploit hosts will be outcompeted by those that exploit hosts more rapidly. Even if host life expectancy is reduced so that all parasites do worse, prudent parasites do disproportionately worse and are thus eliminated by natural selection.
The majority of mixed-infection models of virulence assume that more virulent strains have a competitive advantage. Logical as this may seem, there is hardly any experimental evidence to suggest that this is indeed the case, and some evidence that the opposite is true (Read & Taylor 2001) . Within-host competition is certainly widespread and is mediated by limited resources, strain-transcending immune responses (apparent competition) or direct interference between competing genotypes (Read & Taylor 2001) . In rodent malaria, for example, both resource and apparent competition probably play a role (Snounou et al. 1989 (Snounou et al. , 1992 Hellriegel 1992; Taylor et al. 1997a; Taylor & Read 1998; Read & Taylor 2001; De Roode et al. 2003) . But, while strains with a higher growth rate probably will do better in resource competition, they could also become a preferred target of strain-specific immune responses, giving less-abundant genotypes an advantage (Bruce et al. 2000; Read et al. 2002) .
If there is a lack of experimental evidence to suggest that virulent clones are competitively superior to avirulent clones, there is even less evidence that any superiority is consistent across genetically different hosts. Numerous studies have shown that disease virulence varies with host genotype, with some host types being more susceptible to severe disease than others (e.g. Stevenson et al. 1982; Ebert & Hamilton 1996; Ebert et al. 1998; Imhoof & Schmid-Hempel 1998; Carius et al. 2001; . This variation in resistance is likely to be reflected in variation in the strengths of resource-or immune-mediated competition between parasites within hosts. Indeed, one study has now shown that this is the case: an experiment on the endophyte Epichloë bromicola parasitic on the grass Bromus erectus showed that parasite strains that competitively excluded some strains on one host genotype were excluded themselves on another (Wille et al. 2002) .
Here, we ask whether host genotype is also an important determinant of competitive outcome in a model of human disease. We studied mixed infections of virulent and avirulent clones of the rodent malaria parasite Plasmodium chabaudi in two different strains of laboratory mice. Based on the theory outlined above, we predicted that the virulent parasite clone would rapidly outgrow the avirulent clone in both mouse strains. This did occur in one mouse strain, but in the other competitive suppression was transient, with the avirulent clone persisting to do better in the chronic phase of the infection than it would have done on its own.
MATERIAL AND METHODS

(a) Parasites and hosts
We used two genetically distinct P. chabaudi chabaudi clones, denoted AS(pyr1A) and AJ. AS(pyr1A) was derived through pyrimethamine selection from clone AS (Walliker et al. 1975) . Both AS and AJ were originally isolated from thicket rats (Beale et al. 1978) . For simplicity AS(pyr1A) will be referred to as AS from here on. We chose AS and AJ clones because they differ in their growth rates and virulences (Mackinnon & Read 1999) , with AS producing fewer parasites and causing less virulence than AJ.
Hosts were eight-week-old C57Bl/6J and CBA/Ca inbred female mice (Ann Walker, University of Edinburgh). They were fed on 41B maintenance diet (Harlan, UK) and their drinking water was supplemented with 0.05% para-amino benzoic acid to enhance parasite growth ( Jacobs 1964) . They were kept in a 12 L : 12 D cycle. We will refer to these mouse strains as C57 and CBA from here on.
(b) Experimental design and inoculation of mice with parasites
The experiment consisted of three treatments for both C57 and CBA mice: infections with AS alone infections with AJ alone and mixed ASϩAJ infections. Each treatment group had five mice, resulting in 30 mice in total. Mice infected with just AS or AJ received 10 6 parasites, whereas mice infected with both clones received 2 × 10 6 parasites, made up of 10 6 AS and 10 6 AJ parasites. The latter quantity was chosen because in our analysis we wanted to compare the performance of a clone on its own with its performance in a mixed infection, requiring equal numbers of each parasite clone at inoculation. Although mice that were infected with both clones received a double dose of parasites, we know from previous work that a twofold difference in parasite numbers has a negligible effect on parasite dynamics and virulence (Timms et al. 2001) . We prepared inoculations from donor mice by diluting blood in 0.1 ml of calf serum solution (50% heat-inactivated calf serum, 50% Ringer's solution (27 mM of KCl, 27 mM of CaCl 2 and 0.15 M of NaCl) and 20 units of heparin ml Ϫ1 mouse blood), and injected them via the intraperitoneum. All procedures were carried out under Home Office guidelines.
(c) Monitoring of virulence and infections
To monitor virulence, we recorded mouse live weights and densities of red blood cells (using flow cytometry; Beckman Coulter). Both body mass and red blood cell density decrease dramatically during infection, and these decreases correlate with host mortality and thus virulence .
To monitor production of asexual parasites and gametocytes (the sexual transmission stages) we took thin blood smears from tail blood. These were fixed with methanol and stained with Giemsa to determine levels of asexual parasitaemia and Proc. R. Soc. Lond. B (2004) gametocytaemia using 1000× microscopy. When asexual parasitaemia was high, we counted 500 red blood cells in at least four microscopic fields. With lower parasitaemias and gametocytaemias we counted at least 20 microscopic fields (corresponding to at least 10 000 red blood cells), and calculated the average number of cells per field. Gametocyte numbers were counted using polarized light. We calculated parasite densities and gametocyte densities as the products of parasitaemias and gametocytaemias, respectively, and red blood cell densities taken on the same day.
We took measurements every day from day 0 to day 23 postinfection (PI), three times a week from day 23 to day 48 PI, once a week from day 48 to day 69 PI and on day 83 PI, when the experiment was terminated. Measurements were taken between 09.00 and 10.30, when peripheral blood almost exclusively harboured haploid ring stages of the parasites.
(d ) Monitoring of individual clones in mixed infections
We collected 5 µl samples of tail blood from mice harbouring mixed infections in citrate saline. After 1 min of centrifugation at 13 000 r.p.m., we removed the supernatant and stored the pelleted blood at Ϫ70°C for subsequent DNA extraction using Instagene Matrix (BioRad). We used real-time quantitative PCR to measure the DNA concentrations of both AS and AJ in these samples (Cheesman et al. 2003) and calculated the proportions of AS and AJ in the total parasite population. Absolute numbers of AS and AJ were then calculated by multiplying these proportions by the overall parasite density on the same day.
We took blood samples on the same days that we took our other measurements, but performed PCRs only when parasitaemias were higher than 0.1%, which is the lowest level at which we can accurately estimate AS and AJ proportions (Cheesman et al. 2003) . Our real-time quantitative PCR protocols cannot distinguish between asexual parasites and gametocytes, and so they estimate the densities of all parasites. In our data analyses, we treated these as estimates of asexual density. Gametocyte densities were two to three orders of magnitude lower than asexual-parasite densities, and gametocytes are thus a negligible component of overall parasite numbers.
(e) Trait definition
Prior to statistical analysis we defined and constructed the following traits that described part of or all of the infection. For measures of virulence we determined the 'minimum weight' and 'minimum density of red blood cells' that mice reached. Mice that died were included in our analysis of minimum weights and red blood cell densities, using weight and red blood cell density on the day of death as the minima they reached. For all other traits, these mice were excluded from the analyses.
Parasite levels in mice rose and fell several times, with the first peak being substantially higher and lasting for longer than the other peaks. For each mouse, we calculated the period until the end of the first wave, and defined this as the acute phase of the infection. The subsequent period, the chronic phase, was defined as starting on the day that parasite numbers began to recover after the collapse of the first wave (day 15.6 ± 0.55 PI; mean ± 1 s.e.). To calculate the numbers of parasites present during the whole infection and during the acute and chronic phases, we calculated the areas under the relevant parasite density by day PI curves. As our limit of detecting parasites was ca. 100 µl Ϫ1 , we treated observations of zero parasites as being 100 parasites µl Ϫ1 . We could accurately quantify AS and AJ proportions of 0.01 at levels of 0.1% parasitaemia or higher (Cheesman et al. 2003) ; below that we set the clone densities at our limit of detection (100 µl
Ϫ1
). Parasite densities in single infections were set to the same level when parasitaemias were lower than 0.001%.
For gametocytes, we chose slightly different ways of calculating densities, as they showed different dynamics from asexual parasites, having a first wave before day 9 and one or several thereafter. We therefore calculated the total gametocyte densities over days 0-9 and days 10-83 PI, as well as the total density over the whole infection. We were able to analyse overall numbers of gametocytes only, as our real-time quantitative PCR protocol does not distinguish between AS and AJ gametocytes (see § 2d).
(f ) Statistical analysis
We analysed all traits mentioned in § 2e using ANOVAs and ANCOVAs in Minitab (v. 13.30, Minitab Inc.) . The explanatory variables used were mouse 'strain' and infection 'treatment'. Strain had two factor levels (C57 and CBA); treatment had up to three factor levels (AS, AJ and ASϩAJ), depending on the analysis. For all our models we first fitted the maximal model including covariate (when relevant), treatment, strain and an interaction between treatment and strain. We then minimized the models by removing non-significant terms ( p Ͼ 0.05), beginning with the interaction.
We log-transformed initial and minimum densities of red blood cells as well as all parasite and gametocyte densities prior to analysis, to meet the necessary normality and homogeneityof-variance assumptions.
(g) Follow-up experiment
To confirm the most important findings of this study, we infected groups of five C57 and five CBA mice with ASϩAJ, exactly as described in § 2b, and took blood samples from them on days 6 and 13 PI. We then extracted DNA and analysed these DNA samples with real-time quantitative PCR, to determine whether both clones were present, and in what proportions.
RESULTS
One C57 mouse infected with AJ died on day 12 and one infected with ASϩAJ died on day 7; two CBA mice infected with ASϩAJ died on days 10 and 11 PI. AJ infections induced greater weight loss and lower minimum red blood cell densities than AS infections (treatment: F 1,17 = 25.4, p Ͻ 0.001; and treatment: F 1,18 = 25.3, p Ͻ 0.001, respectively), regardless of mouse genotype (strain and treatment × strain n.s.). Thus, as found previously, AS was the less virulent clone.
(a) AS and AJ parasite densities
In mixed infections in both C57 and CBA mice, there were substantially more AJ than AS parasites during the first 10-14 days ( figure 1a,b) . After day 10, AS disappeared below detectable levels in C57 mice and never reappeared. It persisted, however, in the three CBA mice that survived the first two weeks. One of these experienced separate AS and AJ parasite waves around days 35 and 55 PI (figure 2a). In the other two mice, AS started to overgrow AJ around days 22 and 18, respectively ( figure 2b,c) .
Proc. R. Soc. Lond. B (2004) Later in the infection AJ overgrew AS again in one of these (figure 2c).
Formal analysis confirmed this picture. During the acute phase in both mouse strains, AS was competitively suppressed by AJ, producing far fewer parasites in mixed infections than it did alone (figures 1c,d and 3a; treatment: F 1,13 = 155, p Ͻ 0.001). This suppression was greater in CBA than in C57 mice (treatment × strain: F 1,13 = 9.1, p = 0.01). In C57 mice, AS disappeared below detectable levels before the end of the acute phase, showing competitive exclusion.
In CBA mice, AS was also competitively suppressed during the acute phase, but it was not excluded from the infection. During the chronic phase, it produced more parasites than it would have done on its own (figures 1d and 3b; treatment: F 1,13 = 6.8, p = 0.022; treatment × strain: F 1,13 = 34, p Ͻ 0.001), thus showing that, after the chronic phase, AS actually benefited from the presence of AJ (that is, facilitation, not competition). During both the acute and chronic phases, AS produced more parasites in CBA mice than in C57 mice, whether it was alone or in a mixture (figure 3a,b; strain: F 1,13 = 125, p Ͻ 0.001; F 1,13 = 52, p Ͻ 0.001, respectively).
During the acute phase, AJ produced roughly the same numbers of parasites in mixed and single infections, in both C57 and CBA mice (figures 1e,f and 3c; treatment: F 1,12 = 1.42, p = 0.25), thus showing that, unlike AS, AJ did not suffer from competition. Like AS, it produced more parasites in CBA than in C57 mice (strain: F 1,14 = 27, p Ͻ 0.001). During the chronic phase, AJ produced slightly fewer parasites in C57 mice, but more in CBA mice, than it did on its own (figure 3d; treatment × strain: F 1,12 = 8.1, p = 0.015). When analysing these numbers for CBA mice only, however, there was no difference between single and mixed infections (treatment: F 1,6 = 2.7, p = 0.15), thus showing that, unlike AS, AJ did not experience facilitation during this phase.
(b) Follow-up experiment
In the follow-up experiment, we infected another five C57 and five CBA mice with ASϩAJ, and sampled these on day 6 and day 13 PI. In both mouse strains AS was present on day 6. By day 13, however, AS had disappeared below detectable levels in the peripheral blood of C57 mice (figure 4a), but was still present in CBA mice (figure 4b), actually overgrowing AJ at this time. These results thus confirmed the qualitatively different dynamics of mixed infections in C57 and CBA mice observed in the main experiment.
(c) Overall parasite densities
During the acute phase, infections in C57 mice consisted of fewer parasites than those in CBA mice (figure 3e; strain: F 1,20 = 110, p Ͻ 0.001). In both mouse strains, AJ and ASϩAJ infections produced more parasites during the acute phase than did AS infections (treatment: F 2,20 = 74, p Ͻ 0.001).
During the chronic phase, AJ and ASϩAJ infections produced more parasites than did AS infections (figure 3f; treatment: F 2,20 = 28, p Ͻ 0.001). AJ and ASϩAJ infections also differed from each other, but differently in the two mouse genotypes: in C57 mice ASϩAJ infections produced slightly fewer parasites than AJ infections, whereas All data points are based on five replicate mice, except for single AJ infections in C57 mice (four mice after day 12), mixed ASϩAJ infections in C57 mice (four mice after day 7) and mixed ASϩAJ infections in CBA mice (four mice on day 11 and three mice from day 12 onwards). As the limit of detection was 100 parasites µl Ϫ1 blood, y-axes start at 2.
in CBA mice they produced more (figure 3f; treatment × strain: F 2,20 = 11, p = 0.001). Owing to these higher numbers in CBA mice during the chronic phase, ASϩAJ infections produced more parasites in CBA mice over the whole of the infection than did AJ infections (treatment × strain: F 2,24 = 26, p Ͻ 0.001).
(d ) Gametocyte densities
In C57 mice, most gametocytes were produced during the first 9 days of the infection, with AS having lower densities than AJ and ASϩAJ (figure 5a; treatment: F 2,27 = 11.71, p Ͻ 0.001), whereas in CBA mice most gametocytes were produced after day 9 PI, when AJ produced fewer gametocytes than AS and ASϩAJ (figure 5b; treatment: F 2,20 = 5.0, p = 0.017; strain: F 1,20 = 6.04, p = 0.023; treatment × strain: F 2,20 = 6.1, p = 0.009). In C57 mice, gametocyte peaks in mixed infections mostly resembled those in AJ infections, the numerically dominant clone (figures 5a and 1a) . In CBA mice, mixed infections produced gametocyte dynamics that did not resemble gametocyte production in either AS or AJ single infections, but which peaked during a period when both clones were present in high numbers (figures 5b and 1b) . Summarized over the whole infection, AJ produced most gametocytes in C57 mice, but fewest in CBA mice, in Proc. R. Soc. Lond. B (2004) which AS produced most (strain: F 1,20 = 8.6, p = 0.008; treatment × strain: F 2,20 = 8.3, p = 0.002).
DISCUSSION
Our results show that host genotype affects the outcome of within-host competition between pathogen strains. In C57 mice, the avirulent clone disappeared below detectable levels from the peripheral blood after 10 days of the infection and produced far fewer parasites than it would have done on its own. This competitive suppression almost certainly reduced the clone's transmission potential: the period of greatest gametocyte production in single infections occurred after day 10 PI (figure 5a). As the avirulent clone never reappeared during the course of our study, it seems that it was competitively excluded, something we have not observed before (Taylor et al. 1997b; Taylor & Read 1998; Read et al. 2002; A. F. Read and M. A. Anwar, unpublished data) . By contrast, the virulent clone did not suffer at all from competition in mixed infections.
In CBA mice, the avirulent clone was also competitively suppressed during the acute phase, but it persisted and went on to produce more parasites during the chronic phase than it would have done on its own. Thus, in CBA mice, competitive suppression gave way to facilitation. This may have resulted in enhanced transmission: the density of the avirulent clone peaked at around day 20 PI and coincided with a large gametocyte peak (figures 1d and 5b). Whether the presence of the more virulent clone actually enhanced the overall fitness of the avirulent clone would depend on the host mortality rate induced by the virulent clone and on how many of the gametocytes produced around this time were of the virulent clone. Our experiment, with just two parasite clones and two mouse strains, generated the whole spectrum of outcomes currently captured in a range of different mixed-strain models of virulence evolution. In extreme coinfection models, clone dynamics are unaffected by the presence of other clones (e.g. May & Nowak 1995; Leung & Forbes 1998) ; in our experiments, this was so for clone AJ in both mouse strains. Coexistence with competitive suppression of at least one clone, as envisaged in other models (e.g. Sasaki & Iwasa 1991; Frank 1992 Frank , 1996 Herre 1995; Van Baalen & Sabelis 1995) , occurred within CBA mice. Finally, the competitive exclusion of AS from C57 mice before much transmission-stage production occurred bears substantial resemblance to superinfection models Proc. R. Soc. Lond. B (2004) (which are perhaps better called superseding infection models; Van Baalen & Sabelis 1995) . These models allow no coexistence and postulate that competitive suppression instantly reduces transmission to zero (e.g. Levin & Pimentel 1981; Bremermann & Pickering 1983; Bremermann & Thieme 1989; Knolle 1989; Nowak & May 1994; Leung & Forbes 1998; Gandon et al. 2002) . Thus, it may prove difficult to capture the real-world complexities of a disease such as malaria (and others; Hood 2003) in models that assume that the outcome of competition is independent of environmental conditions, such as host genotype.
A general conclusion of the above models is that mixedclone infections will generate selection for increased virulence. However, the precise details of competition will affect the transient evolutionary dynamics and the magnitude of standing virulence in a population, which is what is relevant to animal and human health. Competitive exclusion of avirulent clones, for instance, will affect potential evolutionary trajectories, rates of evolution and average levels of virulence in a population.
Several recent studies have shown that parasite virulence depends on host genotype (e.g. Ebert & Hamilton 1996; Ebert et al. 1998; Imhoof & Schmid-Hempel 1998; Carius et al. 2001; Mackinnon et al. 2002) , and theory has shown that such host-genotype dependence of virulence can explain why polymorphisms in growth rate and virulence are maintained (Regoes et al. 2000) . If the outcome of competition is as dependent on host genotype as is the expression of virulence itself, this could also contribute to the maintenance of growth-rate and virulence polymorphisms in the parasite population. Wille et al. (2002) also suggested this when they found that some strains of the endophyte E. bromicola competitively excluded other strains on one genotype of its host B. erectus, but not on another.
Clone AS was competitively suppressed by AJ, except during the chronic phases of infections in CBA mice, where AS did better than it did on its own. This could be the result of a combination of strain-specific immunity and antigenic variation. In two of the surviving CBA mice we saw AS overgrow AJ after it had been suppressed (figure 2b,c). This might suggest that the immune system had been focusing on the clone that had produced the highest number of parasites up until then (AJ), giving AS some advantage. Strain-specific immunity is certainly well known in P. chabaudi (e.g. Jarra & Brown 1985; Buckling & Read 2001; R. Carter, unpublished results) , and facilitation of one pathogen as a result of the immune response focusing on another has also been suggested for fungal species infecting leaf-cutter ants (Hughes & Boomsma 2004) . Plasmodium chabaudi is also known to produce antigenic variants at high rates (McLean et al. 1982 (McLean et al. , 1990 Brannan et al. 1994; Phillips et al. 1997) . Novel antigenic variants escape variant-specific host responses, and when there are more clones in an infection, each generating variants, it seems likely that the immune response may be less efficient at controlling the infection. A combination of strain-specific immunity and antigenic variation has also been suggested to play a role in mixedspecies and mixed-strain infections of plasmodia in humans (Bruce et al. 2000) . their resistance to P. chabaudi infections (Stevenson et al. 1982) . Resistance is associated with reduced parasite densities, and appears to be a complex genetic trait, involving many genes affecting immunity and the production and characteristics of red blood cells (Stevenson et al. 1982; Yap et al. 1994; Fortin et al. 2002) . Parasite densities were higher in CBA mice (figure 3e), and such higher densities could reduce the chance of stochastic loss and increase the chance of producing antigenic escape variants.
If differences in overall immune control do explain the strain differences in the outcome of competition, we would expect to find coexistence of the two parasite clones in C57 mice that were made more susceptible, for example by administration of anti-interleukin 12 monoclonal antibodies (Yap et al. 1994) . Conversely, we would expect clone AS to disappear in CBA mice that were made more resistant, for example by artificially increasing their interleukin-12 levels (Yap et al. 1994) .
If overall resistance does affect the outcome of withinhost competition, then we would expect to find differences not only between host genotypes, but also between individuals that differ in their sex, nutritional or health status, vaccination status, or any other factor that influences resistance. Semi-immune mice are much more resistant to cannot be used to distinguish between AS and AJ gametocytes. All data points are based on five replicate mice, except for single AJ infections in C57 mice (four mice after day 12), mixed ASϩAJ infections in C57 mice (four mice after day 7) and mixed ASϩAJ infections in CBA mice (four mice on day 11 and three mice from day 12 onwards). As the limit of detection was 100 gametocytes µl Ϫ1 blood, y-axes start at 2. P. chabaudi infection than are naive mice (Buckling & Read 2001; . Extrapolating from our results, we would expect that only the virulent clone would survive in such vaccinated hosts. It is important to test this, because this implies that vaccination could increase the frequency of virulent clones in a population, thus leading to unforeseen consequences of vaccination (Gandon et al. 2001 (Gandon et al. , 2003 Read et al. 2004) .
